nodes	percent_of_prediction	percent_of_DWPC	metapath
Linagliptin—CYP3A4—breast cancer	0.186	0.546	CbGaD
Linagliptin—ABCB1—breast cancer	0.155	0.454	CbGaD
Linagliptin—ABCB1—Toremifene—breast cancer	0.0422	0.0909	CbGbCtD
Linagliptin—CYP3A4—Exemestane—breast cancer	0.0365	0.0786	CbGbCtD
Linagliptin—CYP3A4—Letrozole—breast cancer	0.031	0.0668	CbGbCtD
Linagliptin—ABCB1—Lapatinib—breast cancer	0.0308	0.0663	CbGbCtD
Linagliptin—CYP3A4—Anastrozole—breast cancer	0.0276	0.0596	CbGbCtD
Linagliptin—CYP3A4—Toremifene—breast cancer	0.0253	0.0545	CbGbCtD
Linagliptin—CYP3A4—Fulvestrant—breast cancer	0.0235	0.0507	CbGbCtD
Linagliptin—CYP3A4—Thiotepa—breast cancer	0.0209	0.0451	CbGbCtD
Linagliptin—CYP3A4—Ixabepilone—breast cancer	0.0191	0.0413	CbGbCtD
Linagliptin—CYP3A4—Lapatinib—breast cancer	0.0184	0.0397	CbGbCtD
Linagliptin—ABCB1—Vinorelbine—breast cancer	0.0171	0.0368	CbGbCtD
Linagliptin—ABCB1—Tamoxifen—breast cancer	0.0154	0.0332	CbGbCtD
Linagliptin—ABCB1—Mitoxantrone—breast cancer	0.015	0.0324	CbGbCtD
Linagliptin—CYP3A4—Raloxifene—breast cancer	0.014	0.0301	CbGbCtD
Linagliptin—ABCB1—Gemcitabine—breast cancer	0.0133	0.0286	CbGbCtD
Linagliptin—ABCB1—Paclitaxel—breast cancer	0.012	0.0259	CbGbCtD
Linagliptin—ABCB1—Irinotecan—breast cancer	0.0118	0.0255	CbGbCtD
Linagliptin—ABCB1—Vinblastine—breast cancer	0.0105	0.0227	CbGbCtD
Linagliptin—CYP3A4—Vinorelbine—breast cancer	0.0102	0.022	CbGbCtD
Linagliptin—CYP3A4—Tamoxifen—breast cancer	0.00923	0.0199	CbGbCtD
Linagliptin—CYP3A4—Mitoxantrone—breast cancer	0.009	0.0194	CbGbCtD
Linagliptin—ABCB1—Docetaxel—breast cancer	0.00867	0.0187	CbGbCtD
Linagliptin—CYP3A4—Paclitaxel—breast cancer	0.00718	0.0155	CbGbCtD
Linagliptin—CYP3A4—Irinotecan—breast cancer	0.00709	0.0153	CbGbCtD
Linagliptin—ABCB1—Doxorubicin—breast cancer	0.00646	0.0139	CbGbCtD
Linagliptin—CYP3A4—Vinblastine—breast cancer	0.0063	0.0136	CbGbCtD
Linagliptin—ABCB1—Methotrexate—breast cancer	0.00626	0.0135	CbGbCtD
Linagliptin—CYP3A4—Docetaxel—breast cancer	0.00519	0.0112	CbGbCtD
Linagliptin—CYP3A4—Doxorubicin—breast cancer	0.00387	0.00835	CbGbCtD
Linagliptin—Alogliptin—CYP2D6—breast cancer	0.00171	0.538	CrCbGaD
Linagliptin—Alogliptin—CYP3A4—breast cancer	0.00147	0.462	CrCbGaD
Linagliptin—DPP4—embryo—breast cancer	0.00106	0.108	CbGeAlD
Linagliptin—DPP4—epithelium—breast cancer	0.000864	0.0885	CbGeAlD
Linagliptin—DPP4—endometrium—breast cancer	0.000775	0.0794	CbGeAlD
Linagliptin—DPP4—uterus—breast cancer	0.000714	0.0731	CbGeAlD
Linagliptin—DPP4—adipose tissue—breast cancer	0.000698	0.0715	CbGeAlD
Linagliptin—DPP4—female reproductive system—breast cancer	0.000642	0.0657	CbGeAlD
Linagliptin—DPP4—adrenal gland—breast cancer	0.000627	0.0642	CbGeAlD
Linagliptin—DPP4—bone marrow—breast cancer	0.000606	0.0621	CbGeAlD
Linagliptin—DPP4—female gonad—breast cancer	0.000584	0.0598	CbGeAlD
Linagliptin—DPP4—endocrine gland—breast cancer	0.000543	0.0556	CbGeAlD
Linagliptin—DPP4—lymph node—breast cancer	0.000376	0.0385	CbGeAlD
Linagliptin—ABCB1—embryo—breast cancer	0.000244	0.025	CbGeAlD
Linagliptin—CYP3A4—female reproductive system—breast cancer	0.000209	0.0214	CbGeAlD
Linagliptin—Unspecified disorder of skin and subcutaneous tissue—Thiotepa—breast cancer	0.000205	0.00143	CcSEcCtD
Linagliptin—Gastrointestinal disorder—Melphalan—breast cancer	0.000205	0.00143	CcSEcCtD
Linagliptin—Back pain—Irinotecan—breast cancer	0.000203	0.00141	CcSEcCtD
Linagliptin—Back pain—Mitoxantrone—breast cancer	0.000203	0.00141	CcSEcCtD
Linagliptin—Skin disorder—Vinorelbine—breast cancer	0.000201	0.00141	CcSEcCtD
Linagliptin—Hypersensitivity—Chlorambucil—breast cancer	0.000201	0.0014	CcSEcCtD
Linagliptin—ABCB1—epithelium—breast cancer	0.000199	0.0204	CbGeAlD
Linagliptin—Diabetes mellitus—Methotrexate—breast cancer	0.000199	0.00139	CcSEcCtD
Linagliptin—Constipation—Goserelin—breast cancer	0.000198	0.00138	CcSEcCtD
Linagliptin—Back pain—Gemcitabine—breast cancer	0.000198	0.00138	CcSEcCtD
Linagliptin—Skin exfoliation—Doxorubicin—breast cancer	0.000198	0.00138	CcSEcCtD
Linagliptin—Infection—Thiotepa—breast cancer	0.000197	0.00137	CcSEcCtD
Linagliptin—Urticaria—Tamoxifen—breast cancer	0.000193	0.00134	CcSEcCtD
Linagliptin—Skin disorder—Thiotepa—breast cancer	0.000192	0.00134	CcSEcCtD
Linagliptin—Weight increased—Docetaxel—breast cancer	0.000189	0.00132	CcSEcCtD
Linagliptin—Musculoskeletal discomfort—Vinorelbine—breast cancer	0.000189	0.00132	CcSEcCtD
Linagliptin—Urticaria—Melphalan—breast cancer	0.000189	0.00132	CcSEcCtD
Linagliptin—Upper respiratory tract infection—Capecitabine—breast cancer	0.000187	0.00131	CcSEcCtD
Linagliptin—Diabetes mellitus—Epirubicin—breast cancer	0.000187	0.0013	CcSEcCtD
Linagliptin—Diarrhoea—Chlorambucil—breast cancer	0.000186	0.0013	CcSEcCtD
Linagliptin—Infestation—Docetaxel—breast cancer	0.000185	0.00129	CcSEcCtD
Linagliptin—Infestation NOS—Docetaxel—breast cancer	0.000185	0.00129	CcSEcCtD
Linagliptin—Urticaria—Goserelin—breast cancer	0.000184	0.00128	CcSEcCtD
Linagliptin—Hypersensitivity—Vinblastine—breast cancer	0.000184	0.00128	CcSEcCtD
Linagliptin—Weight increased—Capecitabine—breast cancer	0.000183	0.00128	CcSEcCtD
Linagliptin—Cough—Irinotecan—breast cancer	0.000183	0.00128	CcSEcCtD
Linagliptin—Cough—Mitoxantrone—breast cancer	0.000183	0.00128	CcSEcCtD
Linagliptin—Musculoskeletal discomfort—Thiotepa—breast cancer	0.00018	0.00126	CcSEcCtD
Linagliptin—Infestation—Capecitabine—breast cancer	0.00018	0.00125	CcSEcCtD
Linagliptin—Infestation NOS—Capecitabine—breast cancer	0.00018	0.00125	CcSEcCtD
Linagliptin—Gastrointestinal disorder—Vinorelbine—breast cancer	0.000179	0.00125	CcSEcCtD
Linagliptin—ABCB1—endometrium—breast cancer	0.000179	0.0183	CbGeAlD
Linagliptin—Hypersensitivity—Tamoxifen—breast cancer	0.000179	0.00125	CcSEcCtD
Linagliptin—Arthralgia—Mitoxantrone—breast cancer	0.000178	0.00125	CcSEcCtD
Linagliptin—Myalgia—Mitoxantrone—breast cancer	0.000178	0.00125	CcSEcCtD
Linagliptin—Cough—Gemcitabine—breast cancer	0.000178	0.00124	CcSEcCtD
Linagliptin—Constipation—Vinorelbine—breast cancer	0.000177	0.00124	CcSEcCtD
Linagliptin—Immune system disorder—Paclitaxel—breast cancer	0.000177	0.00124	CcSEcCtD
Linagliptin—CYP3A4—endocrine gland—breast cancer	0.000177	0.0181	CbGeAlD
Linagliptin—Mediastinal disorder—Paclitaxel—breast cancer	0.000177	0.00123	CcSEcCtD
Linagliptin—Hypersensitivity—Melphalan—breast cancer	0.000175	0.00122	CcSEcCtD
Linagliptin—Urinary tract infection—Capecitabine—breast cancer	0.000175	0.00122	CcSEcCtD
Linagliptin—Myalgia—Gemcitabine—breast cancer	0.000174	0.00121	CcSEcCtD
Linagliptin—Arthralgia—Gemcitabine—breast cancer	0.000174	0.00121	CcSEcCtD
Linagliptin—Diabetes mellitus—Doxorubicin—breast cancer	0.000173	0.0012	CcSEcCtD
Linagliptin—Unspecified disorder of skin and subcutaneous tissue—Gemcitabine—breast cancer	0.000173	0.0012	CcSEcCtD
Linagliptin—Anaphylactic shock—Irinotecan—breast cancer	0.000171	0.00119	CcSEcCtD
Linagliptin—Anaphylactic shock—Mitoxantrone—breast cancer	0.000171	0.00119	CcSEcCtD
Linagliptin—Gastrointestinal disorder—Thiotepa—breast cancer	0.000171	0.00119	CcSEcCtD
Linagliptin—Malnutrition—Paclitaxel—breast cancer	0.000171	0.00119	CcSEcCtD
Linagliptin—Myalgia—Fluorouracil—breast cancer	0.000171	0.00119	CcSEcCtD
Linagliptin—Diarrhoea—Vinblastine—breast cancer	0.000171	0.00119	CcSEcCtD
Linagliptin—Hypersensitivity—Goserelin—breast cancer	0.000171	0.00119	CcSEcCtD
Linagliptin—Infection—Mitoxantrone—breast cancer	0.00017	0.00119	CcSEcCtD
Linagliptin—Infection—Irinotecan—breast cancer	0.00017	0.00119	CcSEcCtD
Linagliptin—Constipation—Thiotepa—breast cancer	0.000169	0.00118	CcSEcCtD
Linagliptin—Anaphylactic shock—Gemcitabine—breast cancer	0.000167	0.00116	CcSEcCtD
Linagliptin—Hypoglycaemia—Epirubicin—breast cancer	0.000166	0.00116	CcSEcCtD
Linagliptin—Skin disorder—Mitoxantrone—breast cancer	0.000166	0.00116	CcSEcCtD
Linagliptin—Diarrhoea—Tamoxifen—breast cancer	0.000166	0.00116	CcSEcCtD
Linagliptin—Infection—Gemcitabine—breast cancer	0.000166	0.00116	CcSEcCtD
Linagliptin—Back pain—Paclitaxel—breast cancer	0.000165	0.00115	CcSEcCtD
Linagliptin—ABCB1—uterus—breast cancer	0.000165	0.0169	CbGeAlD
Linagliptin—Urticaria—Vinorelbine—breast cancer	0.000165	0.00115	CcSEcCtD
Linagliptin—Anaphylactic shock—Fluorouracil—breast cancer	0.000164	0.00114	CcSEcCtD
Linagliptin—Infection—Fluorouracil—breast cancer	0.000163	0.00114	CcSEcCtD
Linagliptin—Diarrhoea—Melphalan—breast cancer	0.000162	0.00113	CcSEcCtD
Linagliptin—Pain in extremity—Epirubicin—breast cancer	0.000162	0.00113	CcSEcCtD
Linagliptin—ABCB1—pituitary gland—breast cancer	0.000162	0.0166	CbGeAlD
Linagliptin—Skin disorder—Gemcitabine—breast cancer	0.000162	0.00113	CcSEcCtD
Linagliptin—ABCB1—adipose tissue—breast cancer	0.000161	0.0165	CbGeAlD
Linagliptin—Diarrhoea—Goserelin—breast cancer	0.000158	0.00111	CcSEcCtD
Linagliptin—Urticaria—Thiotepa—breast cancer	0.000157	0.0011	CcSEcCtD
Linagliptin—Headache—Vinblastine—breast cancer	0.000156	0.00109	CcSEcCtD
Linagliptin—Angioedema—Paclitaxel—breast cancer	0.000156	0.00109	CcSEcCtD
Linagliptin—Musculoskeletal discomfort—Mitoxantrone—breast cancer	0.000156	0.00109	CcSEcCtD
Linagliptin—Hypoglycaemia—Doxorubicin—breast cancer	0.000154	0.00107	CcSEcCtD
Linagliptin—Rash—Tamoxifen—breast cancer	0.000153	0.00107	CcSEcCtD
Linagliptin—Hypersensitivity—Vinorelbine—breast cancer	0.000153	0.00107	CcSEcCtD
Linagliptin—Dermatitis—Tamoxifen—breast cancer	0.000153	0.00107	CcSEcCtD
Linagliptin—Headache—Tamoxifen—breast cancer	0.000152	0.00106	CcSEcCtD
Linagliptin—Musculoskeletal discomfort—Gemcitabine—breast cancer	0.000152	0.00106	CcSEcCtD
Linagliptin—Immune system disorder—Docetaxel—breast cancer	0.00015	0.00105	CcSEcCtD
Linagliptin—Pain in extremity—Doxorubicin—breast cancer	0.00015	0.00105	CcSEcCtD
Linagliptin—Mediastinal disorder—Docetaxel—breast cancer	0.00015	0.00105	CcSEcCtD
Linagliptin—Rash—Melphalan—breast cancer	0.00015	0.00104	CcSEcCtD
Linagliptin—Dermatitis—Melphalan—breast cancer	0.00015	0.00104	CcSEcCtD
Linagliptin—Musculoskeletal discomfort—Fluorouracil—breast cancer	0.000149	0.00104	CcSEcCtD
Linagliptin—Cough—Paclitaxel—breast cancer	0.000149	0.00104	CcSEcCtD
Linagliptin—ABCB1—female reproductive system—breast cancer	0.000148	0.0152	CbGeAlD
Linagliptin—Gastrointestinal disorder—Irinotecan—breast cancer	0.000148	0.00103	CcSEcCtD
Linagliptin—Pancreatitis—Methotrexate—breast cancer	0.000147	0.00103	CcSEcCtD
Linagliptin—Constipation—Mitoxantrone—breast cancer	0.000146	0.00102	CcSEcCtD
Linagliptin—Constipation—Irinotecan—breast cancer	0.000146	0.00102	CcSEcCtD
Linagliptin—Rash—Goserelin—breast cancer	0.000146	0.00102	CcSEcCtD
Linagliptin—Hypersensitivity—Thiotepa—breast cancer	0.000146	0.00102	CcSEcCtD
Linagliptin—Dermatitis—Goserelin—breast cancer	0.000146	0.00102	CcSEcCtD
Linagliptin—Immune system disorder—Capecitabine—breast cancer	0.000146	0.00102	CcSEcCtD
Linagliptin—Myalgia—Paclitaxel—breast cancer	0.000146	0.00102	CcSEcCtD
Linagliptin—Arthralgia—Paclitaxel—breast cancer	0.000146	0.00102	CcSEcCtD
Linagliptin—Mediastinal disorder—Capecitabine—breast cancer	0.000145	0.00101	CcSEcCtD
Linagliptin—Nasopharyngitis—Epirubicin—breast cancer	0.000145	0.00101	CcSEcCtD
Linagliptin—Headache—Goserelin—breast cancer	0.000145	0.00101	CcSEcCtD
Linagliptin—Malnutrition—Docetaxel—breast cancer	0.000145	0.00101	CcSEcCtD
Linagliptin—ABCB1—adrenal gland—breast cancer	0.000145	0.0148	CbGeAlD
Linagliptin—Unspecified disorder of skin and subcutaneous tissue—Paclitaxel—breast cancer	0.000145	0.00101	CcSEcCtD
Linagliptin—Gastrointestinal disorder—Gemcitabine—breast cancer	0.000144	0.001	CcSEcCtD
Linagliptin—Constipation—Gemcitabine—breast cancer	0.000143	0.000994	CcSEcCtD
Linagliptin—Diarrhoea—Vinorelbine—breast cancer	0.000142	0.00099	CcSEcCtD
Linagliptin—Gastrointestinal disorder—Fluorouracil—breast cancer	0.000141	0.000987	CcSEcCtD
Linagliptin—Malnutrition—Capecitabine—breast cancer	0.00014	0.000979	CcSEcCtD
Linagliptin—Back pain—Docetaxel—breast cancer	0.00014	0.000978	CcSEcCtD
Linagliptin—ABCB1—bone marrow—breast cancer	0.00014	0.0143	CbGeAlD
Linagliptin—Anaphylactic shock—Paclitaxel—breast cancer	0.00014	0.000973	CcSEcCtD
Linagliptin—Upper respiratory tract infection—Methotrexate—breast cancer	0.000139	0.000972	CcSEcCtD
Linagliptin—Infection—Paclitaxel—breast cancer	0.000139	0.000967	CcSEcCtD
Linagliptin—Pancreatitis—Epirubicin—breast cancer	0.000138	0.000959	CcSEcCtD
Linagliptin—Urticaria—Mitoxantrone—breast cancer	0.000136	0.000948	CcSEcCtD
Linagliptin—Back pain—Capecitabine—breast cancer	0.000136	0.000947	CcSEcCtD
Linagliptin—Diarrhoea—Thiotepa—breast cancer	0.000136	0.000946	CcSEcCtD
Linagliptin—Skin disorder—Paclitaxel—breast cancer	0.000136	0.000945	CcSEcCtD
Linagliptin—ABCB1—female gonad—breast cancer	0.000135	0.0138	CbGeAlD
Linagliptin—Nasopharyngitis—Doxorubicin—breast cancer	0.000134	0.000937	CcSEcCtD
Linagliptin—Infestation NOS—Methotrexate—breast cancer	0.000134	0.000932	CcSEcCtD
Linagliptin—Infestation—Methotrexate—breast cancer	0.000134	0.000932	CcSEcCtD
Linagliptin—Rash—Vinorelbine—breast cancer	0.000131	0.000912	CcSEcCtD
Linagliptin—Dermatitis—Vinorelbine—breast cancer	0.000131	0.000912	CcSEcCtD
Linagliptin—Upper respiratory tract infection—Epirubicin—breast cancer	0.00013	0.00091	CcSEcCtD
Linagliptin—Urticaria—Fluorouracil—breast cancer	0.00013	0.000908	CcSEcCtD
Linagliptin—Headache—Vinorelbine—breast cancer	0.00013	0.000907	CcSEcCtD
Linagliptin—Weight increased—Epirubicin—breast cancer	0.000128	0.000891	CcSEcCtD
Linagliptin—Pancreatitis—Doxorubicin—breast cancer	0.000127	0.000888	CcSEcCtD
Linagliptin—Musculoskeletal discomfort—Paclitaxel—breast cancer	0.000127	0.000887	CcSEcCtD
Linagliptin—Cough—Docetaxel—breast cancer	0.000126	0.000882	CcSEcCtD
Linagliptin—Hypersensitivity—Irinotecan—breast cancer	0.000126	0.000879	CcSEcCtD
Linagliptin—Hypersensitivity—Mitoxantrone—breast cancer	0.000126	0.000879	CcSEcCtD
Linagliptin—ABCB1—endocrine gland—breast cancer	0.000125	0.0128	CbGeAlD
Linagliptin—Infestation—Epirubicin—breast cancer	0.000125	0.000873	CcSEcCtD
Linagliptin—Infestation NOS—Epirubicin—breast cancer	0.000125	0.000873	CcSEcCtD
Linagliptin—Rash—Thiotepa—breast cancer	0.000125	0.000871	CcSEcCtD
Linagliptin—Dermatitis—Thiotepa—breast cancer	0.000125	0.000871	CcSEcCtD
Linagliptin—Headache—Thiotepa—breast cancer	0.000124	0.000866	CcSEcCtD
Linagliptin—Myalgia—Docetaxel—breast cancer	0.000123	0.000861	CcSEcCtD
Linagliptin—Arthralgia—Docetaxel—breast cancer	0.000123	0.000861	CcSEcCtD
Linagliptin—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—breast cancer	0.000123	0.000855	CcSEcCtD
Linagliptin—Cough—Capecitabine—breast cancer	0.000122	0.000854	CcSEcCtD
Linagliptin—Urinary tract infection—Epirubicin—breast cancer	0.000122	0.000848	CcSEcCtD
Linagliptin—Hypersensitivity—Fluorouracil—breast cancer	0.000121	0.000842	CcSEcCtD
Linagliptin—Upper respiratory tract infection—Doxorubicin—breast cancer	0.000121	0.000842	CcSEcCtD
Linagliptin—Gastrointestinal disorder—Paclitaxel—breast cancer	0.00012	0.00084	CcSEcCtD
Linagliptin—Myalgia—Capecitabine—breast cancer	0.000119	0.000833	CcSEcCtD
Linagliptin—Arthralgia—Capecitabine—breast cancer	0.000119	0.000833	CcSEcCtD
Linagliptin—Constipation—Paclitaxel—breast cancer	0.000119	0.000832	CcSEcCtD
Linagliptin—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—breast cancer	0.000119	0.000828	CcSEcCtD
Linagliptin—Anaphylactic shock—Docetaxel—breast cancer	0.000118	0.000825	CcSEcCtD
Linagliptin—Weight increased—Doxorubicin—breast cancer	0.000118	0.000824	CcSEcCtD
Linagliptin—Infection—Docetaxel—breast cancer	0.000117	0.00082	CcSEcCtD
Linagliptin—Diarrhoea—Irinotecan—breast cancer	0.000117	0.000817	CcSEcCtD
Linagliptin—Diarrhoea—Mitoxantrone—breast cancer	0.000117	0.000817	CcSEcCtD
Linagliptin—Infestation NOS—Doxorubicin—breast cancer	0.000116	0.000807	CcSEcCtD
Linagliptin—Infestation—Doxorubicin—breast cancer	0.000116	0.000807	CcSEcCtD
Linagliptin—Skin disorder—Docetaxel—breast cancer	0.000115	0.000801	CcSEcCtD
Linagliptin—Diarrhoea—Gemcitabine—breast cancer	0.000114	0.000795	CcSEcCtD
Linagliptin—Infection—Capecitabine—breast cancer	0.000114	0.000794	CcSEcCtD
Linagliptin—Urinary tract infection—Doxorubicin—breast cancer	0.000112	0.000785	CcSEcCtD
Linagliptin—Diarrhoea—Fluorouracil—breast cancer	0.000112	0.000782	CcSEcCtD
Linagliptin—Skin disorder—Capecitabine—breast cancer	0.000111	0.000776	CcSEcCtD
Linagliptin—Urticaria—Paclitaxel—breast cancer	0.000111	0.000773	CcSEcCtD
Linagliptin—Immune system disorder—Methotrexate—breast cancer	0.000108	0.000756	CcSEcCtD
Linagliptin—Mediastinal disorder—Methotrexate—breast cancer	0.000108	0.000754	CcSEcCtD
Linagliptin—Rash—Mitoxantrone—breast cancer	0.000108	0.000753	CcSEcCtD
Linagliptin—Rash—Irinotecan—breast cancer	0.000108	0.000753	CcSEcCtD
Linagliptin—Dermatitis—Mitoxantrone—breast cancer	0.000108	0.000752	CcSEcCtD
Linagliptin—Dermatitis—Irinotecan—breast cancer	0.000108	0.000752	CcSEcCtD
Linagliptin—Musculoskeletal discomfort—Docetaxel—breast cancer	0.000108	0.000752	CcSEcCtD
Linagliptin—Headache—Irinotecan—breast cancer	0.000107	0.000748	CcSEcCtD
Linagliptin—Headache—Mitoxantrone—breast cancer	0.000107	0.000748	CcSEcCtD
Linagliptin—Rash—Gemcitabine—breast cancer	0.000105	0.000733	CcSEcCtD
Linagliptin—Dermatitis—Gemcitabine—breast cancer	0.000105	0.000732	CcSEcCtD
Linagliptin—Malnutrition—Methotrexate—breast cancer	0.000104	0.000729	CcSEcCtD
Linagliptin—Headache—Gemcitabine—breast cancer	0.000104	0.000728	CcSEcCtD
Linagliptin—Musculoskeletal discomfort—Capecitabine—breast cancer	0.000104	0.000728	CcSEcCtD
Linagliptin—Rash—Fluorouracil—breast cancer	0.000103	0.000721	CcSEcCtD
Linagliptin—Dermatitis—Fluorouracil—breast cancer	0.000103	0.00072	CcSEcCtD
Linagliptin—Hypersensitivity—Paclitaxel—breast cancer	0.000103	0.000717	CcSEcCtD
Linagliptin—Headache—Fluorouracil—breast cancer	0.000103	0.000716	CcSEcCtD
Linagliptin—Gastrointestinal disorder—Docetaxel—breast cancer	0.000102	0.000712	CcSEcCtD
Linagliptin—Immune system disorder—Epirubicin—breast cancer	0.000101	0.000707	CcSEcCtD
Linagliptin—Mediastinal disorder—Epirubicin—breast cancer	0.000101	0.000706	CcSEcCtD
Linagliptin—Constipation—Docetaxel—breast cancer	0.000101	0.000706	CcSEcCtD
Linagliptin—Back pain—Methotrexate—breast cancer	0.000101	0.000705	CcSEcCtD
Linagliptin—Gastrointestinal disorder—Capecitabine—breast cancer	9.89e-05	0.00069	CcSEcCtD
Linagliptin—Constipation—Capecitabine—breast cancer	9.79e-05	0.000683	CcSEcCtD
Linagliptin—Malnutrition—Epirubicin—breast cancer	9.77e-05	0.000682	CcSEcCtD
Linagliptin—Diarrhoea—Paclitaxel—breast cancer	9.55e-05	0.000666	CcSEcCtD
Linagliptin—Back pain—Epirubicin—breast cancer	9.45e-05	0.00066	CcSEcCtD
Linagliptin—Immune system disorder—Doxorubicin—breast cancer	9.38e-05	0.000655	CcSEcCtD
Linagliptin—Mediastinal disorder—Doxorubicin—breast cancer	9.36e-05	0.000653	CcSEcCtD
Linagliptin—Cough—Methotrexate—breast cancer	9.11e-05	0.000636	CcSEcCtD
Linagliptin—Urticaria—Capecitabine—breast cancer	9.1e-05	0.000635	CcSEcCtD
Linagliptin—Malnutrition—Doxorubicin—breast cancer	9.04e-05	0.000631	CcSEcCtD
Linagliptin—Arthralgia—Methotrexate—breast cancer	8.89e-05	0.00062	CcSEcCtD
Linagliptin—Myalgia—Methotrexate—breast cancer	8.89e-05	0.00062	CcSEcCtD
Linagliptin—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—breast cancer	8.83e-05	0.000616	CcSEcCtD
Linagliptin—Rash—Paclitaxel—breast cancer	8.8e-05	0.000614	CcSEcCtD
Linagliptin—Dermatitis—Paclitaxel—breast cancer	8.79e-05	0.000613	CcSEcCtD
Linagliptin—Back pain—Doxorubicin—breast cancer	8.75e-05	0.00061	CcSEcCtD
Linagliptin—Headache—Paclitaxel—breast cancer	8.74e-05	0.00061	CcSEcCtD
Linagliptin—Hypersensitivity—Docetaxel—breast cancer	8.71e-05	0.000608	CcSEcCtD
Linagliptin—ABCB1—lymph node—breast cancer	8.67e-05	0.00888	CbGeAlD
Linagliptin—Cough—Epirubicin—breast cancer	8.53e-05	0.000595	CcSEcCtD
Linagliptin—Anaphylactic shock—Methotrexate—breast cancer	8.52e-05	0.000595	CcSEcCtD
Linagliptin—Infection—Methotrexate—breast cancer	8.47e-05	0.000591	CcSEcCtD
Linagliptin—Hypersensitivity—Capecitabine—breast cancer	8.44e-05	0.000589	CcSEcCtD
Linagliptin—Arthralgia—Epirubicin—breast cancer	8.32e-05	0.000581	CcSEcCtD
Linagliptin—Myalgia—Epirubicin—breast cancer	8.32e-05	0.000581	CcSEcCtD
Linagliptin—Skin disorder—Methotrexate—breast cancer	8.28e-05	0.000578	CcSEcCtD
Linagliptin—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—breast cancer	8.26e-05	0.000577	CcSEcCtD
Linagliptin—Diarrhoea—Docetaxel—breast cancer	8.09e-05	0.000565	CcSEcCtD
Linagliptin—Anaphylactic shock—Epirubicin—breast cancer	7.98e-05	0.000556	CcSEcCtD
Linagliptin—Infection—Epirubicin—breast cancer	7.92e-05	0.000553	CcSEcCtD
Linagliptin—Cough—Doxorubicin—breast cancer	7.89e-05	0.000551	CcSEcCtD
Linagliptin—Diarrhoea—Capecitabine—breast cancer	7.83e-05	0.000547	CcSEcCtD
Linagliptin—Musculoskeletal discomfort—Methotrexate—breast cancer	7.77e-05	0.000542	CcSEcCtD
Linagliptin—Skin disorder—Epirubicin—breast cancer	7.75e-05	0.000541	CcSEcCtD
Linagliptin—Myalgia—Doxorubicin—breast cancer	7.7e-05	0.000537	CcSEcCtD
Linagliptin—Arthralgia—Doxorubicin—breast cancer	7.7e-05	0.000537	CcSEcCtD
Linagliptin—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—breast cancer	7.65e-05	0.000533	CcSEcCtD
Linagliptin—Rash—Docetaxel—breast cancer	7.46e-05	0.00052	CcSEcCtD
Linagliptin—Dermatitis—Docetaxel—breast cancer	7.45e-05	0.00052	CcSEcCtD
Linagliptin—Headache—Docetaxel—breast cancer	7.41e-05	0.000517	CcSEcCtD
Linagliptin—Anaphylactic shock—Doxorubicin—breast cancer	7.38e-05	0.000515	CcSEcCtD
Linagliptin—Gastrointestinal disorder—Methotrexate—breast cancer	7.36e-05	0.000513	CcSEcCtD
Linagliptin—Infection—Doxorubicin—breast cancer	7.33e-05	0.000512	CcSEcCtD
Linagliptin—Musculoskeletal discomfort—Epirubicin—breast cancer	7.27e-05	0.000507	CcSEcCtD
Linagliptin—Rash—Capecitabine—breast cancer	7.22e-05	0.000504	CcSEcCtD
Linagliptin—Dermatitis—Capecitabine—breast cancer	7.21e-05	0.000503	CcSEcCtD
Linagliptin—Headache—Capecitabine—breast cancer	7.17e-05	0.0005	CcSEcCtD
Linagliptin—Skin disorder—Doxorubicin—breast cancer	7.17e-05	0.0005	CcSEcCtD
Linagliptin—Gastrointestinal disorder—Epirubicin—breast cancer	6.89e-05	0.00048	CcSEcCtD
Linagliptin—Constipation—Epirubicin—breast cancer	6.82e-05	0.000476	CcSEcCtD
Linagliptin—Urticaria—Methotrexate—breast cancer	6.77e-05	0.000472	CcSEcCtD
Linagliptin—Musculoskeletal discomfort—Doxorubicin—breast cancer	6.72e-05	0.000469	CcSEcCtD
Linagliptin—Gastrointestinal disorder—Doxorubicin—breast cancer	6.37e-05	0.000445	CcSEcCtD
Linagliptin—Urticaria—Epirubicin—breast cancer	6.34e-05	0.000442	CcSEcCtD
Linagliptin—Constipation—Doxorubicin—breast cancer	6.31e-05	0.00044	CcSEcCtD
Linagliptin—Hypersensitivity—Methotrexate—breast cancer	6.28e-05	0.000438	CcSEcCtD
Linagliptin—Hypersensitivity—Epirubicin—breast cancer	5.88e-05	0.00041	CcSEcCtD
Linagliptin—Urticaria—Doxorubicin—breast cancer	5.86e-05	0.000409	CcSEcCtD
Linagliptin—Diarrhoea—Methotrexate—breast cancer	5.83e-05	0.000407	CcSEcCtD
Linagliptin—Diarrhoea—Epirubicin—breast cancer	5.46e-05	0.000381	CcSEcCtD
Linagliptin—Hypersensitivity—Doxorubicin—breast cancer	5.44e-05	0.000379	CcSEcCtD
Linagliptin—Rash—Methotrexate—breast cancer	5.37e-05	0.000375	CcSEcCtD
Linagliptin—Dermatitis—Methotrexate—breast cancer	5.37e-05	0.000375	CcSEcCtD
Linagliptin—Headache—Methotrexate—breast cancer	5.34e-05	0.000373	CcSEcCtD
Linagliptin—Diarrhoea—Doxorubicin—breast cancer	5.05e-05	0.000352	CcSEcCtD
Linagliptin—Rash—Epirubicin—breast cancer	5.03e-05	0.000351	CcSEcCtD
Linagliptin—Dermatitis—Epirubicin—breast cancer	5.02e-05	0.000351	CcSEcCtD
Linagliptin—Headache—Epirubicin—breast cancer	5e-05	0.000349	CcSEcCtD
Linagliptin—Rash—Doxorubicin—breast cancer	4.65e-05	0.000325	CcSEcCtD
Linagliptin—Dermatitis—Doxorubicin—breast cancer	4.65e-05	0.000324	CcSEcCtD
Linagliptin—Headache—Doxorubicin—breast cancer	4.62e-05	0.000323	CcSEcCtD
Linagliptin—ABCB1—Integrated Pancreatic Cancer Pathway—CCNE1—breast cancer	2.89e-05	0.000747	CbGpPWpGaD
Linagliptin—ABCB1—Integrated Pancreatic Cancer Pathway—SMAD4—breast cancer	2.89e-05	0.000747	CbGpPWpGaD
Linagliptin—ABCB1—Transmembrane transport of small molecules—ATP7B—breast cancer	2.85e-05	0.000737	CbGpPWpGaD
Linagliptin—ABCB1—Integrated Pancreatic Cancer Pathway—TYMS—breast cancer	2.84e-05	0.000733	CbGpPWpGaD
Linagliptin—ABCB1—Integrated Pancreatic Cancer Pathway—PLA2G4A—breast cancer	2.81e-05	0.000725	CbGpPWpGaD
Linagliptin—CYP3A4—Biological oxidations—CYP17A1—breast cancer	2.8e-05	0.000722	CbGpPWpGaD
Linagliptin—ABCB1—Integrated Pancreatic Cancer Pathway—FGF1—breast cancer	2.78e-05	0.000717	CbGpPWpGaD
Linagliptin—CYP3A4—Biological oxidations—PTGS1—breast cancer	2.77e-05	0.000715	CbGpPWpGaD
Linagliptin—CYP3A4—Metapathway biotransformation—CYP17A1—breast cancer	2.76e-05	0.000712	CbGpPWpGaD
Linagliptin—ABCB1—Integrated Pancreatic Cancer Pathway—BAX—breast cancer	2.74e-05	0.000706	CbGpPWpGaD
Linagliptin—ABCB1—Integrated Pancreatic Cancer Pathway—E2F1—breast cancer	2.72e-05	0.000701	CbGpPWpGaD
Linagliptin—CYP3A4—Biological oxidations—CYP2D6—breast cancer	2.71e-05	0.000701	CbGpPWpGaD
Linagliptin—CYP3A4—Metapathway biotransformation—CYP2D6—breast cancer	2.68e-05	0.000691	CbGpPWpGaD
Linagliptin—CYP3A4—Biological oxidations—NCOA2—breast cancer	2.66e-05	0.000688	CbGpPWpGaD
Linagliptin—ABCB1—Transmembrane transport of small molecules—ABCC1—breast cancer	2.65e-05	0.000685	CbGpPWpGaD
Linagliptin—ABCB1—Allograft Rejection—VEGFA—breast cancer	2.53e-05	0.000652	CbGpPWpGaD
Linagliptin—ABCB1—Integrated Pancreatic Cancer Pathway—FGFR1—breast cancer	2.4e-05	0.00062	CbGpPWpGaD
Linagliptin—CYP3A4—Biological oxidations—CYP1B1—breast cancer	2.35e-05	0.000608	CbGpPWpGaD
Linagliptin—ABCB1—Integrated Pancreatic Cancer Pathway—CDK2—breast cancer	2.34e-05	0.000605	CbGpPWpGaD
Linagliptin—ABCB1—Metabolism—SYNJ2—breast cancer	2.33e-05	0.000601	CbGpPWpGaD
Linagliptin—CYP3A4—Metapathway biotransformation—CYP1B1—breast cancer	2.32e-05	0.000599	CbGpPWpGaD
Linagliptin—ABCB1—Allograft Rejection—TGFB1—breast cancer	2.32e-05	0.000599	CbGpPWpGaD
Linagliptin—ABCB1—Transmembrane transport of small molecules—TUBB3—breast cancer	2.26e-05	0.000583	CbGpPWpGaD
Linagliptin—CYP3A4—Biological oxidations—NCOA1—breast cancer	2.24e-05	0.00058	CbGpPWpGaD
Linagliptin—ABCB1—Integrated Pancreatic Cancer Pathway—ATM—breast cancer	2.22e-05	0.000574	CbGpPWpGaD
Linagliptin—ABCB1—Integrated Pancreatic Cancer Pathway—CDK4—breast cancer	2.21e-05	0.000572	CbGpPWpGaD
Linagliptin—CYP3A4—Biological oxidations—CYP19A1—breast cancer	2.21e-05	0.000571	CbGpPWpGaD
Linagliptin—ABCB1—Integrated Pancreatic Cancer Pathway—ESR1—breast cancer	2.21e-05	0.000569	CbGpPWpGaD
Linagliptin—CYP3A4—Metapathway biotransformation—CYP19A1—breast cancer	2.18e-05	0.000563	CbGpPWpGaD
Linagliptin—ABCB1—Allograft Rejection—TNF—breast cancer	2.17e-05	0.000559	CbGpPWpGaD
Linagliptin—ABCB1—Metabolism—NDUFS3—breast cancer	2.16e-05	0.000559	CbGpPWpGaD
Linagliptin—ABCB1—Integrated Pancreatic Cancer Pathway—NFKBIA—breast cancer	2.15e-05	0.000556	CbGpPWpGaD
Linagliptin—ABCB1—Integrated Pancreatic Cancer Pathway—APC—breast cancer	2.08e-05	0.000538	CbGpPWpGaD
Linagliptin—ABCB1—Integrated Pancreatic Cancer Pathway—EGF—breast cancer	2.06e-05	0.000532	CbGpPWpGaD
Linagliptin—CYP3A4—Biological oxidations—COMT—breast cancer	2.06e-05	0.000531	CbGpPWpGaD
Linagliptin—CYP3A4—Biological oxidations—GSTP1—breast cancer	2.05e-05	0.000529	CbGpPWpGaD
Linagliptin—ABCB1—Metabolism—CHST9—breast cancer	2.03e-05	0.000526	CbGpPWpGaD
Linagliptin—CYP3A4—Metapathway biotransformation—COMT—breast cancer	2.03e-05	0.000524	CbGpPWpGaD
Linagliptin—CYP3A4—Metapathway biotransformation—GSTP1—breast cancer	2.02e-05	0.000521	CbGpPWpGaD
Linagliptin—ABCB1—Integrated Pancreatic Cancer Pathway—CASP8—breast cancer	1.94e-05	0.000501	CbGpPWpGaD
Linagliptin—ABCB1—Metabolism—COX11—breast cancer	1.93e-05	0.000498	CbGpPWpGaD
Linagliptin—ABCB1—Integrated Pancreatic Cancer Pathway—IGF1—breast cancer	1.91e-05	0.000493	CbGpPWpGaD
Linagliptin—CYP3A4—Biological oxidations—GSTM1—breast cancer	1.88e-05	0.000486	CbGpPWpGaD
Linagliptin—ABCB1—Transmembrane transport of small molecules—SLC2A2—breast cancer	1.88e-05	0.000485	CbGpPWpGaD
Linagliptin—ABCB1—HIF-1-alpha transcription factor network—AKT1—breast cancer	1.86e-05	0.000481	CbGpPWpGaD
Linagliptin—CYP3A4—Metapathway biotransformation—GSTM1—breast cancer	1.85e-05	0.000479	CbGpPWpGaD
Linagliptin—ABCB1—Transmembrane transport of small molecules—ABCG2—breast cancer	1.84e-05	0.000475	CbGpPWpGaD
Linagliptin—CYP3A4—Biological oxidations—CYP1A1—breast cancer	1.78e-05	0.00046	CbGpPWpGaD
Linagliptin—ABCB1—Metabolism—SHMT1—breast cancer	1.76e-05	0.000456	CbGpPWpGaD
Linagliptin—ABCB1—Metabolism—CDA—breast cancer	1.76e-05	0.000456	CbGpPWpGaD
Linagliptin—CYP3A4—Metapathway biotransformation—CYP1A1—breast cancer	1.76e-05	0.000454	CbGpPWpGaD
Linagliptin—ABCB1—Metabolism—SLCO1B1—breast cancer	1.7e-05	0.000439	CbGpPWpGaD
Linagliptin—ABCB1—Metabolism—SLC2A5—breast cancer	1.7e-05	0.000439	CbGpPWpGaD
Linagliptin—ABCB1—Integrated Pancreatic Cancer Pathway—BCL2—breast cancer	1.67e-05	0.00043	CbGpPWpGaD
Linagliptin—ABCB1—Integrated Pancreatic Cancer Pathway—MDM2—breast cancer	1.64e-05	0.000424	CbGpPWpGaD
Linagliptin—ABCB1—Metabolism—APRT—breast cancer	1.64e-05	0.000424	CbGpPWpGaD
Linagliptin—ABCB1—Transmembrane transport of small molecules—TFRC—breast cancer	1.64e-05	0.000423	CbGpPWpGaD
Linagliptin—ABCB1—Integrated Pancreatic Cancer Pathway—RAF1—breast cancer	1.64e-05	0.000422	CbGpPWpGaD
Linagliptin—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—breast cancer	1.62e-05	0.000418	CbGpPWpGaD
Linagliptin—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—breast cancer	1.58e-05	0.000409	CbGpPWpGaD
Linagliptin—ABCB1—Transmembrane transport of small molecules—NCOA2—breast cancer	1.58e-05	0.000408	CbGpPWpGaD
Linagliptin—ABCB1—Metabolism—ESRRA—breast cancer	1.54e-05	0.000398	CbGpPWpGaD
Linagliptin—ABCB1—Metabolism—ANGPTL4—breast cancer	1.54e-05	0.000398	CbGpPWpGaD
Linagliptin—ABCB1—Transmembrane transport of small molecules—SLC5A5—breast cancer	1.51e-05	0.000389	CbGpPWpGaD
Linagliptin—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1B—breast cancer	1.5e-05	0.000387	CbGpPWpGaD
Linagliptin—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—breast cancer	1.47e-05	0.000379	CbGpPWpGaD
Linagliptin—ABCB1—Metabolism—HADHB—breast cancer	1.46e-05	0.000378	CbGpPWpGaD
Linagliptin—ABCB1—Metabolism—GPI—breast cancer	1.46e-05	0.000378	CbGpPWpGaD
Linagliptin—ABCB1—Transmembrane transport of small molecules—SLC2A1—breast cancer	1.45e-05	0.000376	CbGpPWpGaD
Linagliptin—CYP3A4—Metabolism—SYNJ2—breast cancer	1.43e-05	0.00037	CbGpPWpGaD
Linagliptin—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—breast cancer	1.43e-05	0.000369	CbGpPWpGaD
Linagliptin—ABCB1—Integrated Pancreatic Cancer Pathway—JUN—breast cancer	1.43e-05	0.000368	CbGpPWpGaD
Linagliptin—ABCB1—Integrated Pancreatic Cancer Pathway—CTNNB1—breast cancer	1.42e-05	0.000366	CbGpPWpGaD
Linagliptin—ABCB1—Metabolism—ALDH1A1—breast cancer	1.39e-05	0.00036	CbGpPWpGaD
Linagliptin—ABCB1—Metabolism—ALDH7A1—breast cancer	1.39e-05	0.00036	CbGpPWpGaD
Linagliptin—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1A—breast cancer	1.38e-05	0.000357	CbGpPWpGaD
Linagliptin—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—breast cancer	1.38e-05	0.000356	CbGpPWpGaD
Linagliptin—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK8—breast cancer	1.35e-05	0.000349	CbGpPWpGaD
Linagliptin—ABCB1—Metabolism—FHL2—breast cancer	1.34e-05	0.000345	CbGpPWpGaD
Linagliptin—ABCB1—Metabolism—NME1—breast cancer	1.34e-05	0.000345	CbGpPWpGaD
Linagliptin—ABCB1—Metabolism—PHGDH—breast cancer	1.34e-05	0.000345	CbGpPWpGaD
Linagliptin—ABCB1—Metabolism—UMPS—breast cancer	1.34e-05	0.000345	CbGpPWpGaD
Linagliptin—ABCB1—Metabolism—ADSL—breast cancer	1.34e-05	0.000345	CbGpPWpGaD
Linagliptin—CYP3A4—Metabolism—NDUFS3—breast cancer	1.33e-05	0.000344	CbGpPWpGaD
Linagliptin—ABCB1—Transmembrane transport of small molecules—NCOA1—breast cancer	1.33e-05	0.000343	CbGpPWpGaD
Linagliptin—ABCB1—Metabolism—LDHB—breast cancer	1.31e-05	0.000339	CbGpPWpGaD
Linagliptin—ABCB1—Metabolism—BRIP1—breast cancer	1.31e-05	0.000339	CbGpPWpGaD
Linagliptin—ABCB1—Metabolism—HPSE—breast cancer	1.31e-05	0.000339	CbGpPWpGaD
Linagliptin—ABCB1—Transmembrane transport of small molecules—PLG—breast cancer	1.3e-05	0.000335	CbGpPWpGaD
Linagliptin—ABCB1—Integrated Pancreatic Cancer Pathway—SRC—breast cancer	1.28e-05	0.000331	CbGpPWpGaD
Linagliptin—CYP3A4—Metabolism—CHST9—breast cancer	1.25e-05	0.000324	CbGpPWpGaD
Linagliptin—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—breast cancer	1.25e-05	0.000322	CbGpPWpGaD
Linagliptin—ABCB1—Metabolism—HMMR—breast cancer	1.24e-05	0.000321	CbGpPWpGaD
Linagliptin—ABCB1—Metabolism—GSTA3—breast cancer	1.24e-05	0.000321	CbGpPWpGaD
Linagliptin—ABCB1—Metabolism—ABCC1—breast cancer	1.24e-05	0.000321	CbGpPWpGaD
Linagliptin—ABCB1—Metabolism—PPARGC1B—breast cancer	1.2e-05	0.000311	CbGpPWpGaD
Linagliptin—ABCB1—Transmembrane transport of small molecules—HMOX1—breast cancer	1.2e-05	0.000309	CbGpPWpGaD
Linagliptin—CYP3A4—Metabolism—COX11—breast cancer	1.19e-05	0.000307	CbGpPWpGaD
Linagliptin—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK3—breast cancer	1.18e-05	0.000305	CbGpPWpGaD
Linagliptin—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—breast cancer	1.15e-05	0.000296	CbGpPWpGaD
Linagliptin—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—breast cancer	1.14e-05	0.000295	CbGpPWpGaD
Linagliptin—ABCB1—Metabolism—CA9—breast cancer	1.14e-05	0.000294	CbGpPWpGaD
Linagliptin—ABCB1—Metabolism—GSTA4—breast cancer	1.14e-05	0.000294	CbGpPWpGaD
Linagliptin—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—breast cancer	1.12e-05	0.00029	CbGpPWpGaD
Linagliptin—ABCB1—Metabolism—GSTA2—breast cancer	1.11e-05	0.000286	CbGpPWpGaD
Linagliptin—ABCB1—Metabolism—GPX2—breast cancer	1.11e-05	0.000286	CbGpPWpGaD
Linagliptin—ABCB1—Metabolism—SULT1A1—breast cancer	1.09e-05	0.000283	CbGpPWpGaD
Linagliptin—ABCB1—Metabolism—GPX4—breast cancer	1.09e-05	0.000283	CbGpPWpGaD
Linagliptin—CYP3A4—Metabolism—SHMT1—breast cancer	1.09e-05	0.000281	CbGpPWpGaD
Linagliptin—CYP3A4—Metabolism—CDA—breast cancer	1.09e-05	0.000281	CbGpPWpGaD
Linagliptin—ABCB1—Metabolism—IDH1—breast cancer	1.07e-05	0.000276	CbGpPWpGaD
Linagliptin—ABCB1—Metabolism—GSTA1—breast cancer	1.07e-05	0.000276	CbGpPWpGaD
Linagliptin—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—breast cancer	1.07e-05	0.000276	CbGpPWpGaD
Linagliptin—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—breast cancer	1.06e-05	0.000274	CbGpPWpGaD
Linagliptin—ABCB1—Metabolism—NAT2—breast cancer	1.06e-05	0.000273	CbGpPWpGaD
Linagliptin—CYP3A4—Metabolism—SLCO1B1—breast cancer	1.05e-05	0.00027	CbGpPWpGaD
Linagliptin—CYP3A4—Metabolism—SLC2A5—breast cancer	1.05e-05	0.00027	CbGpPWpGaD
Linagliptin—CYP3A4—Metabolism—APRT—breast cancer	1.01e-05	0.000261	CbGpPWpGaD
Linagliptin—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—breast cancer	9.74e-06	0.000251	CbGpPWpGaD
Linagliptin—CYP3A4—Metabolism—ESRRA—breast cancer	9.5e-06	0.000245	CbGpPWpGaD
Linagliptin—CYP3A4—Metabolism—ANGPTL4—breast cancer	9.5e-06	0.000245	CbGpPWpGaD
Linagliptin—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—breast cancer	9.42e-06	0.000243	CbGpPWpGaD
Linagliptin—ABCB1—Metabolism—DPYD—breast cancer	9.27e-06	0.000239	CbGpPWpGaD
Linagliptin—ABCB1—Metabolism—MED12—breast cancer	9.27e-06	0.000239	CbGpPWpGaD
Linagliptin—ABCB1—Metabolism—ALDOA—breast cancer	9.12e-06	0.000236	CbGpPWpGaD
Linagliptin—CYP3A4—Metabolism—GPI—breast cancer	9.01e-06	0.000233	CbGpPWpGaD
Linagliptin—CYP3A4—Metabolism—HADHB—breast cancer	9.01e-06	0.000233	CbGpPWpGaD
Linagliptin—ABCB1—Metabolism—NCOA3—breast cancer	8.86e-06	0.000229	CbGpPWpGaD
Linagliptin—ABCB1—Metabolism—SLC2A2—breast cancer	8.8e-06	0.000227	CbGpPWpGaD
Linagliptin—ABCB1—Metabolism—ABCG2—breast cancer	8.62e-06	0.000223	CbGpPWpGaD
Linagliptin—ABCB1—Metabolism—CPT1A—breast cancer	8.62e-06	0.000223	CbGpPWpGaD
Linagliptin—ABCB1—Metabolism—MTR—breast cancer	8.62e-06	0.000223	CbGpPWpGaD
Linagliptin—CYP3A4—Metabolism—ALDH1A1—breast cancer	8.59e-06	0.000222	CbGpPWpGaD
Linagliptin—CYP3A4—Metabolism—ALDH7A1—breast cancer	8.59e-06	0.000222	CbGpPWpGaD
Linagliptin—ABCB1—Metabolism—HPGDS—breast cancer	8.45e-06	0.000218	CbGpPWpGaD
Linagliptin—ABCB1—Metabolism—HBA1—breast cancer	8.4e-06	0.000217	CbGpPWpGaD
Linagliptin—CYP3A4—Metabolism—PHGDH—breast cancer	8.24e-06	0.000213	CbGpPWpGaD
Linagliptin—CYP3A4—Metabolism—UMPS—breast cancer	8.24e-06	0.000213	CbGpPWpGaD
Linagliptin—CYP3A4—Metabolism—FHL2—breast cancer	8.24e-06	0.000213	CbGpPWpGaD
Linagliptin—CYP3A4—Metabolism—ADSL—breast cancer	8.24e-06	0.000213	CbGpPWpGaD
Linagliptin—CYP3A4—Metabolism—NME1—breast cancer	8.24e-06	0.000213	CbGpPWpGaD
Linagliptin—ABCB1—Metabolism—GSTT1—breast cancer	8.2e-06	0.000212	CbGpPWpGaD
Linagliptin—ABCB1—Metabolism—ACHE—breast cancer	8.2e-06	0.000212	CbGpPWpGaD
Linagliptin—CYP3A4—Metabolism—BRIP1—breast cancer	8.08e-06	0.000209	CbGpPWpGaD
Linagliptin—CYP3A4—Metabolism—HPSE—breast cancer	8.08e-06	0.000209	CbGpPWpGaD
Linagliptin—CYP3A4—Metabolism—LDHB—breast cancer	8.08e-06	0.000209	CbGpPWpGaD
Linagliptin—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—breast cancer	7.95e-06	0.000205	CbGpPWpGaD
Linagliptin—ABCB1—Metabolism—CYP17A1—breast cancer	7.76e-06	0.0002	CbGpPWpGaD
Linagliptin—ABCB1—Metabolism—ENO1—breast cancer	7.68e-06	0.000198	CbGpPWpGaD
Linagliptin—ABCB1—Metabolism—PTGS1—breast cancer	7.68e-06	0.000198	CbGpPWpGaD
Linagliptin—CYP3A4—Metabolism—HMMR—breast cancer	7.66e-06	0.000198	CbGpPWpGaD
Linagliptin—CYP3A4—Metabolism—GSTA3—breast cancer	7.66e-06	0.000198	CbGpPWpGaD
Linagliptin—CYP3A4—Metabolism—ABCC1—breast cancer	7.66e-06	0.000198	CbGpPWpGaD
Linagliptin—ABCB1—Metabolism—CYP2D6—breast cancer	7.53e-06	0.000194	CbGpPWpGaD
Linagliptin—CYP3A4—Metabolism—PPARGC1B—breast cancer	7.42e-06	0.000192	CbGpPWpGaD
Linagliptin—ABCB1—Metabolism—NCOA2—breast cancer	7.39e-06	0.000191	CbGpPWpGaD
Linagliptin—ABCB1—Transmembrane transport of small molecules—ALB—breast cancer	7.18e-06	0.000185	CbGpPWpGaD
Linagliptin—ABCB1—Metabolism—FASN—breast cancer	7.17e-06	0.000185	CbGpPWpGaD
Linagliptin—ABCB1—Metabolism—BCHE—breast cancer	7.14e-06	0.000184	CbGpPWpGaD
Linagliptin—ABCB1—Metabolism—SLC5A5—breast cancer	7.05e-06	0.000182	CbGpPWpGaD
Linagliptin—CYP3A4—Metabolism—CA9—breast cancer	7e-06	0.000181	CbGpPWpGaD
Linagliptin—CYP3A4—Metabolism—GSTA4—breast cancer	7e-06	0.000181	CbGpPWpGaD
Linagliptin—CYP3A4—Metabolism—GPX2—breast cancer	6.83e-06	0.000176	CbGpPWpGaD
Linagliptin—CYP3A4—Metabolism—GSTA2—breast cancer	6.83e-06	0.000176	CbGpPWpGaD
Linagliptin—ABCB1—Metabolism—SLC2A1—breast cancer	6.81e-06	0.000176	CbGpPWpGaD
Linagliptin—ABCB1—Metabolism—NQO1—breast cancer	6.81e-06	0.000176	CbGpPWpGaD
Linagliptin—CYP3A4—Metabolism—GPX4—breast cancer	6.74e-06	0.000174	CbGpPWpGaD
Linagliptin—CYP3A4—Metabolism—SULT1A1—breast cancer	6.74e-06	0.000174	CbGpPWpGaD
Linagliptin—ABCB1—Metabolism—CYP3A4—breast cancer	6.64e-06	0.000172	CbGpPWpGaD
Linagliptin—CYP3A4—Metabolism—IDH1—breast cancer	6.59e-06	0.00017	CbGpPWpGaD
Linagliptin—CYP3A4—Metabolism—GSTA1—breast cancer	6.59e-06	0.00017	CbGpPWpGaD
Linagliptin—ABCB1—Metabolism—CYP1B1—breast cancer	6.53e-06	0.000169	CbGpPWpGaD
Linagliptin—CYP3A4—Metabolism—NAT2—breast cancer	6.51e-06	0.000168	CbGpPWpGaD
Linagliptin—ABCB1—Transmembrane transport of small molecules—RAF1—breast cancer	6.5e-06	0.000168	CbGpPWpGaD
Linagliptin—ABCB1—Metabolism—HSP90AA1—breast cancer	6.4e-06	0.000165	CbGpPWpGaD
Linagliptin—ABCB1—Metabolism—NCOA1—breast cancer	6.23e-06	0.000161	CbGpPWpGaD
Linagliptin—ABCB1—Metabolism—CYP19A1—breast cancer	6.14e-06	0.000159	CbGpPWpGaD
Linagliptin—ABCB1—Metabolism—STK11—breast cancer	6.14e-06	0.000159	CbGpPWpGaD
Linagliptin—CYP3A4—Metabolism—DPYD—breast cancer	5.71e-06	0.000147	CbGpPWpGaD
Linagliptin—CYP3A4—Metabolism—MED12—breast cancer	5.71e-06	0.000147	CbGpPWpGaD
Linagliptin—ABCB1—Metabolism—COMT—breast cancer	5.71e-06	0.000147	CbGpPWpGaD
Linagliptin—ABCB1—Metabolism—GSTP1—breast cancer	5.68e-06	0.000147	CbGpPWpGaD
Linagliptin—CYP3A4—Metabolism—ALDOA—breast cancer	5.62e-06	0.000145	CbGpPWpGaD
Linagliptin—ABCB1—Metabolism—HMOX1—breast cancer	5.6e-06	0.000145	CbGpPWpGaD
Linagliptin—ABCB1—Metabolism—ITPR1—breast cancer	5.59e-06	0.000144	CbGpPWpGaD
Linagliptin—CYP3A4—Metabolism—NCOA3—breast cancer	5.46e-06	0.000141	CbGpPWpGaD
Linagliptin—CYP3A4—Metabolism—SLC2A2—breast cancer	5.42e-06	0.00014	CbGpPWpGaD
Linagliptin—CYP3A4—Metabolism—ABCG2—breast cancer	5.31e-06	0.000137	CbGpPWpGaD
Linagliptin—CYP3A4—Metabolism—CPT1A—breast cancer	5.31e-06	0.000137	CbGpPWpGaD
Linagliptin—CYP3A4—Metabolism—MTR—breast cancer	5.31e-06	0.000137	CbGpPWpGaD
Linagliptin—ABCB1—Metabolism—TYMS—breast cancer	5.28e-06	0.000136	CbGpPWpGaD
Linagliptin—ABCB1—Metabolism—GSTM1—breast cancer	5.22e-06	0.000135	CbGpPWpGaD
Linagliptin—ABCB1—Metabolism—PLA2G4A—breast cancer	5.22e-06	0.000135	CbGpPWpGaD
Linagliptin—ABCB1—Metabolism—NCOR1—breast cancer	5.22e-06	0.000135	CbGpPWpGaD
Linagliptin—CYP3A4—Metabolism—HPGDS—breast cancer	5.21e-06	0.000134	CbGpPWpGaD
Linagliptin—CYP3A4—Metabolism—HBA1—breast cancer	5.17e-06	0.000134	CbGpPWpGaD
Linagliptin—CYP3A4—Metabolism—ACHE—breast cancer	5.05e-06	0.00013	CbGpPWpGaD
Linagliptin—CYP3A4—Metabolism—GSTT1—breast cancer	5.05e-06	0.00013	CbGpPWpGaD
Linagliptin—ABCB1—Metabolism—GPX1—breast cancer	5e-06	0.000129	CbGpPWpGaD
Linagliptin—ABCB1—Metabolism—CYP1A1—breast cancer	4.95e-06	0.000128	CbGpPWpGaD
Linagliptin—ABCB1—Metabolism—ERCC2—breast cancer	4.91e-06	0.000127	CbGpPWpGaD
Linagliptin—CYP3A4—Metabolism—CYP17A1—breast cancer	4.78e-06	0.000123	CbGpPWpGaD
Linagliptin—CYP3A4—Metabolism—PTGS1—breast cancer	4.73e-06	0.000122	CbGpPWpGaD
Linagliptin—CYP3A4—Metabolism—ENO1—breast cancer	4.73e-06	0.000122	CbGpPWpGaD
Linagliptin—CYP3A4—Metabolism—CYP2D6—breast cancer	4.64e-06	0.00012	CbGpPWpGaD
Linagliptin—ABCB1—Metabolism—MTHFR—breast cancer	4.61e-06	0.000119	CbGpPWpGaD
Linagliptin—CYP3A4—Metabolism—NCOA2—breast cancer	4.55e-06	0.000118	CbGpPWpGaD
Linagliptin—CYP3A4—Metabolism—FASN—breast cancer	4.42e-06	0.000114	CbGpPWpGaD
Linagliptin—CYP3A4—Metabolism—BCHE—breast cancer	4.4e-06	0.000114	CbGpPWpGaD
Linagliptin—CYP3A4—Metabolism—SLC5A5—breast cancer	4.35e-06	0.000112	CbGpPWpGaD
Linagliptin—ABCB1—Metabolism—CAV1—breast cancer	4.26e-06	0.00011	CbGpPWpGaD
Linagliptin—CYP3A4—Metabolism—SLC2A1—breast cancer	4.2e-06	0.000108	CbGpPWpGaD
Linagliptin—CYP3A4—Metabolism—NQO1—breast cancer	4.2e-06	0.000108	CbGpPWpGaD
Linagliptin—CYP3A4—Metabolism—CYP1B1—breast cancer	4.02e-06	0.000104	CbGpPWpGaD
Linagliptin—CYP3A4—Metabolism—HSP90AA1—breast cancer	3.95e-06	0.000102	CbGpPWpGaD
Linagliptin—ABCB1—Metabolism—PIK3CG—breast cancer	3.88e-06	0.0001	CbGpPWpGaD
Linagliptin—CYP3A4—Metabolism—NCOA1—breast cancer	3.84e-06	9.91e-05	CbGpPWpGaD
Linagliptin—CYP3A4—Metabolism—STK11—breast cancer	3.78e-06	9.77e-05	CbGpPWpGaD
Linagliptin—CYP3A4—Metabolism—CYP19A1—breast cancer	3.78e-06	9.77e-05	CbGpPWpGaD
Linagliptin—CYP3A4—Metabolism—COMT—breast cancer	3.52e-06	9.08e-05	CbGpPWpGaD
Linagliptin—CYP3A4—Metabolism—GSTP1—breast cancer	3.5e-06	9.04e-05	CbGpPWpGaD
Linagliptin—CYP3A4—Metabolism—HMOX1—breast cancer	3.45e-06	8.91e-05	CbGpPWpGaD
Linagliptin—CYP3A4—Metabolism—ITPR1—breast cancer	3.44e-06	8.89e-05	CbGpPWpGaD
Linagliptin—ABCB1—Metabolism—PIK3CD—breast cancer	3.41e-06	8.8e-05	CbGpPWpGaD
Linagliptin—ABCB1—Metabolism—ALB—breast cancer	3.36e-06	8.69e-05	CbGpPWpGaD
Linagliptin—CYP3A4—Metabolism—ABCB1—breast cancer	3.31e-06	8.56e-05	CbGpPWpGaD
Linagliptin—CYP3A4—Metabolism—TYMS—breast cancer	3.25e-06	8.4e-05	CbGpPWpGaD
Linagliptin—ABCB1—Metabolism—NOS3—breast cancer	3.22e-06	8.31e-05	CbGpPWpGaD
Linagliptin—CYP3A4—Metabolism—NCOR1—breast cancer	3.22e-06	8.31e-05	CbGpPWpGaD
Linagliptin—CYP3A4—Metabolism—PLA2G4A—breast cancer	3.22e-06	8.31e-05	CbGpPWpGaD
Linagliptin—CYP3A4—Metabolism—GSTM1—breast cancer	3.22e-06	8.31e-05	CbGpPWpGaD
Linagliptin—CYP3A4—Metabolism—GPX1—breast cancer	3.08e-06	7.95e-05	CbGpPWpGaD
Linagliptin—CYP3A4—Metabolism—CYP1A1—breast cancer	3.05e-06	7.87e-05	CbGpPWpGaD
Linagliptin—CYP3A4—Metabolism—ERCC2—breast cancer	3.02e-06	7.81e-05	CbGpPWpGaD
Linagliptin—ABCB1—Metabolism—PIK3CB—breast cancer	2.97e-06	7.67e-05	CbGpPWpGaD
Linagliptin—ABCB1—Metabolism—PTGS2—breast cancer	2.94e-06	7.6e-05	CbGpPWpGaD
Linagliptin—CYP3A4—Metabolism—MTHFR—breast cancer	2.84e-06	7.34e-05	CbGpPWpGaD
Linagliptin—CYP3A4—Metabolism—CAV1—breast cancer	2.62e-06	6.77e-05	CbGpPWpGaD
Linagliptin—ABCB1—Metabolism—PTEN—breast cancer	2.57e-06	6.63e-05	CbGpPWpGaD
Linagliptin—CYP3A4—Metabolism—PIK3CG—breast cancer	2.39e-06	6.17e-05	CbGpPWpGaD
Linagliptin—CYP3A4—Metabolism—PIK3CD—breast cancer	2.1e-06	5.42e-05	CbGpPWpGaD
Linagliptin—CYP3A4—Metabolism—ALB—breast cancer	2.07e-06	5.35e-05	CbGpPWpGaD
Linagliptin—CYP3A4—Metabolism—NOS3—breast cancer	1.98e-06	5.12e-05	CbGpPWpGaD
Linagliptin—CYP3A4—Metabolism—PIK3CB—breast cancer	1.83e-06	4.73e-05	CbGpPWpGaD
Linagliptin—CYP3A4—Metabolism—PTGS2—breast cancer	1.81e-06	4.68e-05	CbGpPWpGaD
Linagliptin—ABCB1—Metabolism—PIK3CA—breast cancer	1.81e-06	4.68e-05	CbGpPWpGaD
Linagliptin—CYP3A4—Metabolism—PTEN—breast cancer	1.58e-06	4.08e-05	CbGpPWpGaD
Linagliptin—ABCB1—Metabolism—AKT1—breast cancer	1.48e-06	3.82e-05	CbGpPWpGaD
Linagliptin—CYP3A4—Metabolism—PIK3CA—breast cancer	1.12e-06	2.88e-05	CbGpPWpGaD
Linagliptin—CYP3A4—Metabolism—AKT1—breast cancer	9.11e-07	2.35e-05	CbGpPWpGaD
